PROLIFERATIONSINHIBITOR

Patent europeic · EP4049722 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4049722
Numer da la dumonda
EP20880103
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-10-2020
Publitgà
31-08-2022
Concedì
15-07-2026
La protecziun finescha il pli tard
19-10-2040
Proxima taxa annuala scadenta
31-10-2027
Classas IPC
A61P 3/10 (2006.01)
C12N 5/071 (2010.01)
C12N 5/0735 (2010.01)
C12N 5/10 (2006.01)
C12N 9/99 (2006.01)
A61K 35/545 (2015.01)
A61L 27/38 (2006.01)
Prioritad
JP 2019191876 21.10.2019
Dumonda PCT
PCT/JP2020/039380 20.10.2020
Publicaziun PCT
WO2021/079874 29.04.2021
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-11-2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. 06-08-2026

    Represchentant inscrit

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 06.08.2026

  3. 15-07-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.07.2026

Partidas

Possessur

Orizuru Therapeutics, Inc.

26-1, Muraoka-Higashi 2-chome, Fujisawa-shi Kanagawa 251-8555, JP

Represchentant

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventur

SAKUMA Kensuke

Fujisawa-shi, Kanagawa 251-0012, JP

YAMAZOE Noriko

Fujisawa-shi, Kanagawa 251-0012, JP

TOYODA Taro

Kyoto-shi, Kyoto 606-8501, JP

KONAGAYA Shuhei

Kyoto-shi, Kyoto 606-8501, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.